Zingo FDA Approval History
FDA Approved: Yes (First approved August 16, 2007)
Brand name: Zingo
Generic name: lidocaine hydrochloride monohydrate
Dosage form: Dermal PowderJect
Company: Anesiva, Inc.
Treatment for: Local Anesthesia
Zingo (lidocaine hydrochloride monohydrate) is a needle-free, local anesthetic intradermal injection system, which provides rapid, topical, local analgesia to reduce the pain associated with venous access procedures, such as IV insertions or blood draws.
Development Timeline for Zingo
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.